Picture of Recursion Pharmaceuticals logo

RXRX — Recursion Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Recursion Pharmaceuticals Inc reports results for the quarter ended in January - Earnings Summary

* Recursion Pharmaceuticals Inc  RXRX.OQ  reported a
quarterly
adjusted loss of 39 cents​​ per share for the quarter ended in
January, lower than the same quarter last year, when the company
reported EPS of -34 cents.  The mean expectation of six analysts
for the quarter was for a loss of 42 cents per share. Wall
Street expected results to range from -46 cents to -39 cents per
share.
    * Revenue rose 13.7% to $13.79 million from a year ago;
analysts
expected $12.65 million. 
    * Recursion Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 39 cents​.
    * The company reported a quarterly loss of $91.37 million.
    * Recursion Pharmaceuticals Inc shares had fallen by 13.8%
this
quarter and lost 12.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 1.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 5
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"

Wall Street's median 12-month price target for Recursion
Pharmaceuticals Inc is $12.50 
This summary was machine generated from LSEG data May 9 at 10:28
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.42          -0.39          Beat
 Dec. 31 2023      -0.45          -0.42          Beat
 Sep. 30 2023      -0.38          -0.43          Missed
 Jun. 30 2023      -0.37          -0.38          Missed

Recent news on Recursion Pharmaceuticals

See all news